World Journal of Surgery

, Volume 32, Issue 9, pp 1924–1929 | Cite as

Evaluation of Breast Lymphatic Pathways with Indocyanine Green Fluorescence Imaging in Patients with Breast Cancer

  • Yutaka Ogasawara
  • Hirokuni Ikeda
  • Mina Takahashi
  • Kensuke Kawasaki
  • Hiroyoshi Doihara
Article

Abstract

Background

In patients with early breast cancer, sentinel lymph node biopsy (SLNB) has been emerging as a new standard of care. The use of SLNB with a blue dye is convenient and safe, but it requires a high level of technical skill. Recently, an instrument that can provide fluorescence imaging of lymphatic flow has been introduced. In the present study, we analyzed breast lymphatic pathways and discussed its potential as a modality to complement the use of SLNB with a blue dye.

Methods

Thirty-seven consecutive patients with breast cancer were examined. To obtain fluorescence imaging, an invisible near-infrared fluorescence imaging system was used. After indocyanine green was subdermally injected in the subareolar site and at two sites around the tumor, the subcutaneous lymphatic drainage pathway (LDP) was observed.

Results

In 27 (72.9%) of the patients, the number of LDP from the periareolar area was one or two. In 21(63.6%) of 33 patients with subdermal injection around the tumor, no LDP was observed from the peritumoral area. Lymphatic connection between the peritumoral area and the periareolar area was observed very frequently (91.7%). In 26 (70.3%) of the patients, multiple routes joined together and only one route was ultimately directed to the axilla. Significant correlation was seen between body mass index (BMI) and the transit time to the axilla after injection (p = 0.0038). Additionally, a significant correlation was seen between the number of LPD from the periareolar area and the distance between detected SLNs and the fluorescence line-disappearing point (p = 0.034).

Conclusions

This instrument can provide some important information, and can be an available and reliable navigator for SLNB with a blue dye.

Keywords

Sentinel Lymph Node Sentinel Lymph Node Biopsy Axillary Lymph Node Dissection Lymphatic Drainage Lymphatic Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Bass SS, Cox CE, Ku NN et al (1999) The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 189:184–194CrossRefGoogle Scholar
  2. 2.
    Giuliano AE, Jones RC, Brennan MB et al (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345–2350PubMedGoogle Scholar
  3. 3.
    Veronesi U, Paganelli G, Galimberti V et al (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349:1864–1867PubMedCrossRefGoogle Scholar
  4. 4.
    Borgstein PJ, Pijpers R, Comans EF et al (1998) Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275–283PubMedCrossRefGoogle Scholar
  5. 5.
    Nwariaku FE, Euhus DM, Beitsch et al (1998) Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer. Am J Surg 176:529–531Google Scholar
  6. 6.
    Morton DL, Wen DR, Wong JH et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399PubMedGoogle Scholar
  7. 7.
    Cabanas RM (1997) An approach for the treatment of penile carcinoma. Cancer 39:456–466CrossRefGoogle Scholar
  8. 8.
    Morton DL, Wen DR, Foshag LJ et al (1993) Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 11:1751–1756PubMedGoogle Scholar
  9. 9.
    Cabanas RM (1992) Anatomy and biopsy of sentinel lymph nodes. Urol Clin North Am 19:267–276PubMedGoogle Scholar
  10. 10.
    Glass LF, Fenske NA, Messina JL et al (1995) The role of selective lymphadenectomy in the management of patients with malignant melanoma. Dermatol Surg 21:979–983PubMedCrossRefGoogle Scholar
  11. 11.
    Krag DN, Weaver DL, Alex JC et al (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335–339PubMedCrossRefGoogle Scholar
  12. 12.
    Giuliano AE, Kirgan DM, Guenther JM et al (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398PubMedCrossRefGoogle Scholar
  13. 13.
    Minato M, Hirose C, Sasa M et al (2004) 3-dimensional computed tomography lymphography-guided identification of sentinel lymph nodes in breast cancer patients using subcutaneus injection of nonionic contrast medium. J Comput Assist Tomogr 28:46–51PubMedCrossRefGoogle Scholar
  14. 14.
    Motomura K, Inaji H, Komoike Y et al (1999) Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol 29:604–607PubMedCrossRefGoogle Scholar
  15. 15.
    Tanaka E, Choi HS, Fujii H et al (2006) Image-guided oncologic surgery using invisible light: completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 13:1671–1681PubMedCrossRefGoogle Scholar
  16. 16.
    Guenther JM, Krishnamoorthy M, Tan LR (1997) Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 3:336–340PubMedGoogle Scholar
  17. 17.
    Pijpers R, Meijer S, Hoekstra OS et al (1997) Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38:366–368PubMedGoogle Scholar
  18. 18.
    Roumen RM, Valkenburg JG, Geuskens LM (1997) Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 23:495–502PubMedCrossRefGoogle Scholar
  19. 19.
    Mateos JJ, Vidal-Sicart S, Zanon G et al (2001) Sentinel lymph node biopsy in breast cancer patients: subdermal versus peritumoural radiocolloid injection. Nucl Med Commun 22:17–24PubMedCrossRefGoogle Scholar
  20. 20.
    Smith LF, Cross MJ, Klimberg VS (2000) Subareolar injection is a better technique for sentinel lymph node biopsy. Am J Surg 180:434–437PubMedCrossRefGoogle Scholar
  21. 21.
    Bauer TW, Spitz FR, Callans LS et al (2002) Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 9:169–176PubMedCrossRefGoogle Scholar
  22. 22.
    McMasters KM, Wong SL, Martin RC 2nd et al (2001) Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233:676–687PubMedCrossRefGoogle Scholar
  23. 23.
    Golshan M, Martin WJ, Dowlatshahi K (2003) Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 69:209–211PubMedGoogle Scholar
  24. 24.
    Suga K, Yuan Y, Okada M et al (2004) Breast sentinel lymph node mapping at CT lymphography with iopamidol: preliminary experience. Radiology 230:543–552PubMedCrossRefGoogle Scholar
  25. 25.
    Tangoku A, Yamamoto S, Suga K et al (2004) Sentinel lymph node biopsy using computed tomography-lymphography in patients with breast cancer. Surgery 135:258–265PubMedCrossRefGoogle Scholar
  26. 26.
    Borgstein PJ, Meijer S, Pijpers R (1997) Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 349:1668–1669PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2008

Authors and Affiliations

  • Yutaka Ogasawara
    • 1
  • Hirokuni Ikeda
    • 1
  • Mina Takahashi
    • 1
  • Kensuke Kawasaki
    • 1
  • Hiroyoshi Doihara
    • 1
  1. 1.Department of Cancer and Thoracic SurgeryOkayama University Graduate School of Medicine, Dentistry and Pharmaceutical SciencesOkayama-CityJapan

Personalised recommendations